| 141 - 151 |
Solubilization of liposomes by weak electrolyte drugs II. Cefotaxime
Rogers JA, Habib MJ |
| 153 - 167 |
Effect of manufacturing conditions on the formation of double-walled polymer microspheres
Leach K, Noh K, Mathiowitz E |
| 169 - 180 |
Microencapsulation and testing of the agricultural animal repellent, Daphne
Boh B, Kosir I, Knez E, Kukovic M, Skerlavaj V, Skvarc A |
| 181 - 194 |
Cephradin-plaga microspheres for sustained delivery to cattle
Ustariz-Peyret C, Coudane J, Vert M, Kaltsatos V, Boisrame B |
| 195 - 203 |
Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads
Sezer AD, Akbuga J |
| 205 - 213 |
Solid lipid nanoparticles (SLN) for controlled drug delivery II. drug incorporation and physicochemical characterization
Schwarz C, Mehnert W |
| 215 - 229 |
Rhizobacteria microencapsulation: properties of microparticles obtained by spray-drying
Amiet-Charpentier C, Gadille P, Benoit JP |
| 231 - 242 |
Preparation of albumin microspheres by an improved process
Katti D, Krishnamurti N |
| 243 - 250 |
Ocular drug targeting by liposomes and their corneal interactions
Velpandian T, Gupta SK, Gupta YK, Biswas NR, Agarwal HC |
| 251 - 256 |
Preparation of liposomes by reverse-phase evaporation using alternative organic solvents
Cortesi R, Esposito E, Gambarin S, Telloli P, Menegatti E, Nastruzzi C |
